Patient Square Capital has agreed to acquire NanoString Technologies, a provider of life science tools for discovery and translational research, for $220 million. Menlo Park, California-based Patient Square was advised by Kirkland & Ellis. NanoString, which is based in Seattle, was represented by Willkie Farr & Gallagher.
Biotech & Pharmaceuticals
March 11, 2024, 2:56 PM